This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Author: Avi Kapoor | March 11, 2025 08:14am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Keefe, Bruyette & Woods analyst Jade Rahmani downgraded the rating for Lennar Corporation (NYSE:LEN) from Outperform to Market Perform and lowered the price target from $152 to $141. Lennar shares closed at $125.22 on Monday. See how other analysts view this stock.
Morgan Stanley analyst Mauricio Cepeda downgraded Afya Limited (NASDAQ:AFYA) from Equal-Weight to Underweight and cut the price target from $19 to $17. Afya shares closed at $16.97 on Monday. See how other analysts view this stock.
HC Wainwright & Co. analyst Joseph Pantginis downgraded the rating for Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) from Buy to Neutral and announced a $4.1 price target. Checkpoint Therapeutics shares closed at $3.98 on Monday. See how other analysts view this stock.
Jefferies analyst Laurence Alexander downgraded the rating for Green Plains Inc. (NASDAQ:GPRE) from Buy to Hold and lowered the price target from $14 to $6. Green Plains shares closed at $5.48 on Monday. See how other analysts view this stock.
Leerink Partners analyst Daina Graybosch downgraded 2seventy bio, Inc. (NASDAQ:TSVT) from Outperform to Market Perform and lowered the price target from $9 to $5. 2seventy bio shares closed at $2.80 on Monday. See how other analysts view this stock.